Federal Drug Control Service of Russia

EmVenio Research expands clinical research team to streamline efficiency and compliance processes

Retrieved on: 
Monday, August 28, 2023
Institutional review board, Podiatry, Federal Drug Control Service of Russia, Gastroenterology, Diabetes, Scheuring, Public, Leather, Clinical trial, Assessment, Consultant, Employment, Research, Bachelor of Arts in Clinical Psychology, Organization, Creighton University, Dermatology, International Conference on Mechanical Industrial & Energy Engineering, Food and Drug Administration, Adaptive participatory integrated approach, Quality control, Harmonization, Conference, Nursing, Western Kentucky University

DURHAM, N.C., Aug. 28, 2023 /PRNewswire/ -- EmVenio Research recently appointed Christine Scheuring and Vickie Leathers to manage clinical research teams and processes. Scheuring serves as director of quality and compliance and Leathers is the manager of clinical research education and training. Their hiring aligns with EmVenio's goal to ensure that the clinical trial team conducts and will maintain adherence to the latest Federal Drug Administration regulations and in accordance with Good Clinical Practice and International Conference of Harmonization guidelines.

Key Points: 
  • DURHAM, N.C., Aug. 28, 2023 /PRNewswire/ -- EmVenio Research recently appointed Christine Scheuring and Vickie Leathers to manage clinical research teams and processes.
  • Scheuring serves as director of quality and compliance and Leathers is the manager of clinical research education and training.
  • EmVenio Research appointed Christine Scheuring and Vickie Leathers to manage its clinical research teams and processes.
  • "Adding Christine and Vickie reinforces our research team's effort to remain on the forefront of developments in the clinical research realm."

Dayton Children's Hospital Bridges Epic Hyperdrive Migration with PortalGuard® IAM Cloud to Expand its Utilization of BIO-key Identity-Bound Biometrics

Retrieved on: 
Tuesday, April 11, 2023
Hyperspace, IDP, Workforce, Citrix Systems, MFA, International, Federal Drug Control Service of Russia, SAML, EPCS, Hospital, Biometrics, DEA, Dayton Children's Hospital, IBB, OpenID, IAM, Electronic prescribing, Video game, Pharmacy, WALL, Hyperdrive

PortalGuard’s standards-based integration with Hyperdrive allows Dayton Children’s to continue enjoying BIO-key’s streamlined biometric authentication user experience for Epic security without re-enrollment or adoption of more cumbersome, shareable, and expensive multi-factor authentication solutions.

Key Points: 
  • PortalGuard’s standards-based integration with Hyperdrive allows Dayton Children’s to continue enjoying BIO-key’s streamlined biometric authentication user experience for Epic security without re-enrollment or adoption of more cumbersome, shareable, and expensive multi-factor authentication solutions.
  • Hyperdrive is Epic’s new browser-based application platform intended to replace its client-server Citrix-based Hyperspace end-user interface.
  • Hyperdrive’s browser-based access improves security, makes deploying and updating applications easier and allows for more choice in third-party authentication providers.
  • "Many of BIO-key’s hospital customers use Epic, and most are already in Hyperdrive migration engagements with our technical team," said Mark Cochran, President of BIO-key – PortalGuard.

MAG Aerospace and L3Harris Partner to Advance Airborne ISR Mission Needs for US Army

Retrieved on: 
Tuesday, October 11, 2022
Computer, Government, Technology, DOD, Federal Drug Control Service of Russia, NYSE, MAG, ARES, Intelligence, Contract, LHX, Krasukha (electronic warfare system), Multimedia, Partnership, L3Harris Technologies, Innovation, CEO, ISR, MAG Aerospace, Radar, Atmosphere, Army, ATHENA, Engineering, Uranium, Gasoline, Management, Risk management, United States Army

The ATHENA-R aircraft, converted Bombardier Global Express 6500s with ISR mission capabilities, will support U.S. Army missions in the U.S. Indo-Pacific Command area of responsibility.

Key Points: 
  • The ATHENA-R aircraft, converted Bombardier Global Express 6500s with ISR mission capabilities, will support U.S. Army missions in the U.S. Indo-Pacific Command area of responsibility.
  • "This partnership with L3Harris will deliver break-through C5ISR capability to Army combatant commands," said Joseph Reale, CEO, MAG Aerospace.
  • "We have decades of experience creating, evolving and integrating the type of deep-sensing, mission-tailored technologies sought by the Army, while MAG Aerospace is a premier provider of manned and ISR mission operations," said Luke Savoie, President, ISR sector, L3Harris.
  • L3Harris Technologies is an agile global aerospace and defense technology innovator, delivering end-to-end solutions that meet customers' mission-critical needs.

CS Analytical Granted Controlled Dangerous Substance License

Retrieved on: 
Tuesday, September 13, 2022
JP, Glass, Federal Drug Control Service of Russia, New Jersey Department of Health, Elastomer, FDA, DEA, CGMP, EP, CCI, Consumer protection, Program, CDS, False vacuum decay, Achievement, Area studies, USP, Medical device

CLIFTON, N.J., Sept. 13, 2022 /PRNewswire-PRWeb/ -- CS Analytical Laboratory, the world's only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is pleased to announce that it has been granted a Controlled Dangerous Substance license for scheduled drugs under section II through V. The license, granted by the New Jersey Department of Consumer Affairs, in conjunction with the Federal Drug Enforcement Agency, enables CS Analytical to perform testing on controlled and classified drug substances.

Key Points: 
  • CLIFTON, N.J., Sept. 13, 2022 /PRNewswire-PRWeb/ -- CS Analytical Laboratory, the world's only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is pleased to announce that it has been granted a Controlled Dangerous Substance license for scheduled drugs under section II through V. The license, granted by the New Jersey Department of Consumer Affairs, in conjunction with the Federal Drug Enforcement Agency, enables CS Analytical to perform testing on controlled and classified drug substances.
  • "Achievement of a CDS License requires a lengthy and strict adherence to a large number of special requirements and I want to thank the CS Analytical team for their diligence in helping put this program together.
  • The CDS License will allow us to better serve the container testing needs for those manufacturers of controlled drugs," commented Sandra Cincotta, Director of Quality for CS Analytical.
  • CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.

Illinois Department of Transportation Awards Bowman-Lochner Team I-80 Corridor Improvement Project in Will County

Retrieved on: 
Friday, August 5, 2022
Residential Building & Real Estate, Commercial Building & Real Estate, Alternative Energy, Other Professional Services, Construction & Property, Energy, Consulting, Professional Services, Other Transport, Transport, Urban Planning, Landscape, Architecture, Utilities, Other Construction & Property, Federal Drug Control Service of Russia, Consultant, LLC, Environment, Congestion, Engineering, IDOT, Flight Consulting Group, Program, Bowman, Nasdaq, Solution, Illinois Department of Transportation, Time, Vision III Imaging, Inc., Oil, Risk management

Lochner, Inc. (Lochner) have been selected by the Illinois Department of Transportation (IDOT) to provide construction corridor management for improvements to I-80, one of the countrys three coast-to-coast interstates.

Key Points: 
  • Lochner, Inc. (Lochner) have been selected by the Illinois Department of Transportation (IDOT) to provide construction corridor management for improvements to I-80, one of the countrys three coast-to-coast interstates.
  • This 16-mile corridor through Joliet and Will County carries approximately 80,000 vehicles a day.
  • The Bowman-Lochner team provides a unique combination of corridor management and IDOT Phase III engineering experience, and a solid track record of successfully delivering projects on time and on budget for the State of Illinois.
  • Additional team members include GSG Consultants, Inc., Images, Inc., Peralte-Clark, LLC, Program Management & Control Services, LLC, Princeton Technical Services, Inc. and Tecma Associates, Inc.

Savills Completes 150,000 SF Industrial Lease With Bay Cities in Santa Fe Springs

Retrieved on: 
Thursday, December 16, 2021
Organization, Instagram, LinkedIn, Consultant, Workforce, Solution, FDA, Food and Drug Administration, ABC, Tenant, National Organic Program, AIB International, CEO, American Institute, AIB, Savills, Efficiency, Federal Drug Control Service of Russia, City, Alcoholic Beverage Control, Twitter, Technology, Warehouse, Facebook

SANTA FE SPRINGS, Calif., Dec. 16, 2021 /PRNewswire-PRWeb/ -- Savills announced that it completed a 150,000 square-foot lease relocation and expansion on behalf of Bay Cities at 9206 Santa Fe Springs Road, a second-generation, Class A industrial property in Santa Fe Springs.

Key Points: 
  • SANTA FE SPRINGS, Calif., Dec. 16, 2021 /PRNewswire-PRWeb/ -- Savills announced that it completed a 150,000 square-foot lease relocation and expansion on behalf of Bay Cities at 9206 Santa Fe Springs Road, a second-generation, Class A industrial property in Santa Fe Springs.
  • With the addition of the Santa Fe Springs facility, Bay Cities' facilities now consists of over 700,000 square feet of combined space providing the ability to have 20 production lines.
  • Bart Pucci, a senior managing director specializing in industrial and creative office services at Savills, represented Bay Cities' in the 10-year transaction with options to extend.
  • As a longtime advisor to the company, he has represented Bay Cities in its real estate decisions for over 25 years.